Submission Details
| 510(k) Number | K234041 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 2023 |
| Decision Date | April 22, 2024 |
| Days to Decision | 123 days |
| Submission Type | Abbreviated |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K234041 is an FDA 510(k) clearance for the Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA); Fully Automatic Electronic Blood Pressure Monitor (KD-5811BT); Fully Automatic Electronic Blood Pressure Monitor (KD-5810VA); Fully Automatic Electronic Blood Pressure Monitor (KD-5810BT); Fully Automatic Electronic Blood Pressure Monitor (KD-5920VA); Fully Automatic Electronic Blood Pressure Monitor (KD-5920BT); Fully Automatic Electronic Blood Pressure Monitor (KD-5923TS), a System, Measurement, Blood-pressure, Non-invasive (Class II — Special Controls, product code DXN), submitted by Andon Health Co, Ltd. (Tianjin, CN). The FDA issued a Cleared decision on April 22, 2024, 123 days after receiving the submission on December 21, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1130.
| 510(k) Number | K234041 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 2023 |
| Decision Date | April 22, 2024 |
| Days to Decision | 123 days |
| Submission Type | Abbreviated |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXN — System, Measurement, Blood-pressure, Non-invasive |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1130 |